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The role of microRNAs (miRNAs) in infectious diseases is becoming more and more apparent, and the use of miRNAs as a diag-
nostic tool and their therapeutic application has become the major focus of investigation. The aim of this study was to identify 
miRNAs involved in the immune signaling of macrophages in response to Arcobacter (A.) butzleri infection, an emerging food-
borne pathogen causing gastroenteritis. Therefore, primary human macrophages were isolated and infected, and miRNA expression 
was studied by means of RNAseq. Analysis of the data revealed the expression of several miRNAs, which were previously associ-
ated with bacterial infections such as miR-155, miR-125, and miR-212. They were shown to play a key role in Toll-like receptor 
signaling where they act as fine-tuners to establish a balanced immune response. In addition, miRNAs which have yet not been 
identified during bacterial infections such as miR-3613, miR-2116, miR-671, miR-30d, and miR-629 were differentially regulated in 
A. butzleri-infected cells. Targets of these miRNAs accumulated in pathways such as apoptosis and endocytosis – processes that 
might be involved in A. butzleri pathogenesis. Our study contributes new findings about the interaction of A. butzleri with human 
innate immune cells helping to understand underlying regulatory mechanisms in macrophages during infection.
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Introduction
Phagocytic and antigen-presenting cells of the innate im-
mune system such as macrophages or dendritic cells im-
mediately recognize invasive microorganisms, which are 
able to overcome anatomic host barriers such as epithelial 
surfaces and enter the organism. The undisturbed function 
of phagocytes in this fi rst line of host defense is pivotal for 
a successful immune response towards infection.
The effective eradication of pathogens is underlain 
by several signaling events such as Toll-like-recep-
tor (TLR) signaling; many of these are regulated in a 
 miRNA-dependent manner [1]. MicroRNAs (miRNAs) 
are small noncoding RNAs, which negatively infl uence 
gene expression by degradation of mRNA or inhibition 
of protein translation. MiRNA dysregulation in many 
cases leads to disease such as cancer or metabolic disor-
der. As a consequence, the use of miRNAs as a diagnostic 
tool and also the therapeutic application has become the 
major focus of investigation [2]. The role of  miRNAs in 
infectious diseases has become more and more appar-
ent, and there are numerous reports about their involve-
ment in viral and parasite infection. The contribution of 
miRNAs in bacterial diseases has been  explored less. 
However, over the last years, several studies reported 
an increasing evidence of miRNA-mediated host re-
sponse towards bacterial infection [3, 4]. Upon infec-
tion,  miRNAs tightly control immune reactions, involv-
ing both miRNA- mediated unspecifi c cellular responses 
as well as pathogen-dependent regulation of a specifi c 
miRNA expression profi le [5].
Pathogenic species within the family of Campylobac-
teraceae belong to the leading causes for severe gastro-
enteritis worldwide. Within this family, Arcobacter (A.) 
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butzleri is an emerging zoonotic pathogen and has recently 
been associated with cases of diarrhea, peritonitis, and 
bacteremia, but its relevance associated with disease still 
remains to be evaluated [6]. Due to missing routine diag-
nostic and standardized isolation methods, the incidence 
of A. butzleri-associated diseases cannot be properly spec-
ifi ed. Nevertheless, Arcobacter spp. are known to be the 
fourth most common pathogenic group isolated from stool 
specimens of patients with acute enteritis in several pre-
valence studies conducted in Europe [7–9].
Understanding underlying regulatory mechanisms that 
occur in host cells upon Arcobacter infection is indispens-
able to evaluate the pathogenicity and to develop strategies 
to diagnose and combat A. butzleri-induced diseases. Thus, 
the aim of this study was to identify miRNAs expressed in 
innate immune cells in response to an A. butzleri infection. 
For that purpose, primary human macrophages were iso-
lated from three different donors and infected with A. butz-
leri. Subsequent to infection, expression of miRNAs was 
studied by means of RNAseq.
Materials and methods
Bacterial strain and culture condition
A. butzleri reference strain CCUG30485 (Culture Collec-
tion University of Göteborg, Sweden) was cultivated and 
prepared for infection experiments as described previ-
ously [10].
Isolation and cultivation of primary human macrophages
Buffy coats of healthy human donors were obtained at the 
German Red Cross in Berlin Wannsee. Blood mononuclear 
cells were isolated by Ficoll-Paque centrifugation and sub-
sequent attachment to cell-culture fl ask surface. Cells were 
cultivated for 5 days in Gibco macrophage SFM medium 
including 10 μg/ml gentamycin (Biochrom) and 50 ng/ml 
M-CSF (PAN Biotech) (M-CSF stimulus was added for 
2 days).
To determine the percentage of CD14+ cells in the 
isolated cell population, fl uorescence-activated cell sort-
ing (FACS) was performed using a FACSCalibur fl ow cy-
tometer (Becton Dickinson GmbH). The CD14 antibody 
was purchased at Santa Cruz Biotechnology and used at 
a concentration of 1:100. The secondary antibody (IgG2a 
Goat Anti-Mouse, PE labeled, Southern Biotech) was used 
at 1:200.
If FACS analysis proved that the cell population con-
tained more than 80% CD14+ cells, 6 × 105 macrophages 
in 1.5 ml medium per well were seeded in six-well plates 
and used for infection experiments. Cells were incubated 
for another 24 h at 37 °C and 5% CO2 before further exper-
imental use. Monocytes were isolated from three different 
human donors, and infection experiments were reproduced 
in three independent experimental setups.
Infection experiments
Approximately 4–6 × 107 bacterial cells were inoculated 
on 4–6 × 105 primary human macrophages (multiplicity of 
infection [MOI] = 100) and incubated at 37 °C and 5% 
CO2. Noninfected cells served as a negative control. Af-
ter 3 h of infection, cells were washed three times with 
phosphate-buffered solution (PBS) and incubated with 
fresh media containing 300 μg/ml gentamycin for another 
2 h to remove remaining extracellular bacteria. Samples 
were taken 1 h, 5 h, and 24 h after infection. For the 24 h 
time point, cells were treated with 20 μg/ml gentamycin 
for the remaining incubation time. For RNA extraction, 
cells were washed three times with PBS, lysed with RNA 
lysis buffer (mirVANA, Life Technologies) and total RNA 
was isolated according to the manufacturer’s instruction.
Quality control of isolated RNA
Quantity and quality of RNA were fi rst determined by 
measuring absorbance at 260 and 280 nm with a Nano 
Drop 1000 spectrophotometer according to the manufac-
turer’s instructions (Thermo Scientifi c). Samples were 
further analyzed for their RNA integrity with an Agilent 
2100 BioAnalyzer and RNA 6000 Nano Kits (Agilent) ac-
cording to the manufacturer’s protocol. RNA with integ-
rity value (RIN) of ≥9 was used for further investigation.
RNAseq data analysis
Sequencing of small RNA samples was performed at 
the Institute of Clinical Molecular Biology at Christian-
Albrechts-University Kiel, Germany using a HiSeq2500 
device (Illumina) as described earlier [11].
The raw sequencing data were processed as described 
in detail in Leidinger et al.[12]. In brief, we fi rst trimmed 
the 3′ adapter sequence with the FastX toolkit. For quan-
tifi cation (mapping against miRBase release 20) and pre-
diction of novel miRNAs (mapping against human ge-
nome hg19), the miRDeep2 pipeline was applied [13]. We 
summarized the fi nal read counts for known and novel 
miRNAs in an expression matrix and applied quantile 
normalization. For detecting deregulated  miRNAs be-
tween different time points, we applied analysis of vari-
ance (ANOVA). For pair wise group comparisons, we 
applied two-tailed t-tests. All statistical calculations have 
been carried out using R version 3.0.2.
Pathway analysis
To unravel the role of differentially expressed miRNAs 
which have not yet been reported to play a role in bac-
terial infection, in silico prediction was used to identify 
mRNA targets (miRmap, miRmap score <80) [14]. The 
list of  potential target genes was applied to the DAVID 
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functional annotation tool [15, 16] to identify pathways in 
which these potential mRNA targets accumulate.
Validation of potential novel miRNAs
Sequences of three potential novel miRNA candidates 
were selected from the sequencing results, and expres-
sion in macrophages upon infection was validated by 
means of miR-Q, a miRNA-specifi c reverse transcrip-
tion quantitative polymerase chain reaction (RT-qPCR)
[17]. Oligo nucleotides (Table 1) were designed and syn-
thesized (Sigma-Aldrich), and miR-Q assays were per-
formed as described earlier [17] with an annealing tem-
perature of 62 °C. Parallel to amplifi cation of the potential 
novel  miRNAs, reference small RNAs SNORD44 and 
SNORD47 were amplifi ed and used for normalization. 
To determine specifi city of amplifi ed PCR products, melt 
curve analysis and electrophoresis were performed sub-
sequent to amplifi cation.
MiR-Q analysis
The ΔΔCT method [18] was used to calculate the relative 
fold difference of miRNA expression levels compared to 
the negative control. To determine CT values, thresholds 
were set at 0.2.
Ethics
The local Ethics Commission at the Charité Berlin ap-
proved the study (EA1/092/14).
Results
FACS analysis proves high efficiency of macrophage
isolation and enrichment from human buffy coats
Since monocytes only represent a small fraction of leuko-
cytes (2–6%), an enrichment step was necessary to obtain 
a high percentage of monocytes in the leukocyte cell com-
position. For this purpose, monocytes were isolated from 
buffy coats by density centrifugation and subsequent ad-
herence to cell culture fl asks in a differentiation medium. 
Subsequent to cultivation, fl ow cytometry was performed 
to analyze CD14 expression, a cell surface marker for 
monocytes and macrophages, and to reveal the purity of 
the isolated monocyte population. For that purpose, cells 
were stained with a CD14 antibody as well as a second-
ary fl uorochrome-labeled antibody and analyzed with a 
cytometer. The fl uorochrome-stained cells were gated and 
analyzed for CD14 antibody staining. Macrophage frac-
tion in cell culture isolated and cultivated from Donor 1 
constituted 97.02% (Fig. S1, A); from Donor 2, 92.70% 
(Fig. S1, B); and Donor 3, 81.0% (Fig. S1, C).
Sequencing and bioinformatic analysis reveal several 
miRNAs to be regulated upon A. butzleri infection
Since miRNAs were reported to exhibit rapid dynamics in 
their temporal expression in response to bacterial patho-
gens [5, 19], RNA samples of infected macrophages were 
investigated at three different time points to assess chang-
es in miRNA patterns during the course of infection. An 
ANOVA analysis of the RNAseq data revealed 14 anno-
tated human miRNAs, which were signifi cantly regulated 
upon A. butzleri infection. An additional t-test displayed 
signifi cant differences in expression levels compared to 
the noninfected control (Table 2).
According to previous reports regarding regulatory 
functions of miRNAs, they could be grouped into miRNAs 
commonly affected by various bacterial agents and identi-
fi ed as key players in host innate immune response (Fig. 1) 
and those which have not been associated with bacterial 
diseases so far (Fig. 2). Following this, differentially ex-
pressed miRNA in these two groups will be presented.
MiRNAs associated with bacterial infections
MiR-125a, miR-155, miR-212, miR-181c, miR-21, miR-
27a, let-7a, miR-26b, and miR-148b were differentially 
Table 1. Oligonucleotides used for validation of novel miRNAs
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expressed in A. butzleri-infected human macrophages com-
pared to the noninfected control and have previously been 
reported to play a role in host immune response towards 
bacterial infection (Fig. 1). Expression levels of miR-
125a-3p were increased in 5 h and 24 h A. butzleri- infected 
cells compared to respective controls. A continuous in-
Table 2. MiRNAs found to be regulated upon A. butzleri infection
miR Sequence p value (different time points of infection compared
to noninfected control)
125a-3p acaggugagguucuugggagcc 0.038 (24 h vs. n.c.)
155-3p cuccuacauauuagcauuaaca 0.035 (5 h vs. n.c.)
155-5p uuaaugcuaaucgugauaggggu 0.02 (5 h vs. n.c.)
212-3p uaacagucuccagucacggcc 0.034 (24 h vs. n.c.)
181c-5p aacauucaaccugucggugagu 0.034 (24 h vs. n.c.)
21-3p caacaccagucgaugggcugu 0.012 (24 h vs. n.c.)
27a-5p agggcuuagcugcuugugagca 0.049 (1 h vs. n.c.)
let-7a-3p cuauacaaucuacugucuuuc 0.05 (24 h vs. n.c.)
26b-5p uucaaguaauucaggauaggu 0.044 (1 h vs. n.c.), 0.048 (5 h vs. n.c.), 0.004 (24 h vs. n.c.)
148b-3p ucagugcacuacagaacuuugu 0.004 (24 h vs. n.c.)
3613-5p uguuguacuuuuuuuuuuguuc 0.018 (5 h vs. n.c.), 0.019 (24 h vs. n.c.)
2116-3p ccucccaugccaagaacuccc 0.025 (5 h vs. n.c.), 0.032 (24 h vs. n.c.)
671-3p uccgguucucagggcuccacc 0.003 (5 h vs. n.c.), 0.009 (24 h vs. n.c.)
30d-3p cuuucagucagauguuugcugc 0.038 (5 h vs. n.c.)
30d-5p uguaaacauccccgacuggaag 0.035 (24 h vs. n.c.)
629-5p uggguuuacguugggagaacu 0.03 (5 h vs. n.c.)
Fig. 1. MiRNAs associated with bacterial diseases, expressed in primary human macrophages as a response to A. butzleri infection. 
Cells were infected at a MOI of 100. Samples were taken 1 h, 5 h, and 24 h after infection (A.b. = A. butzleri reference strain 
CCUG30485, n.c. = noninfected cells). Asterisks in figures summarize p values (*p < 0.05; **p < 0.01)
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crease could be observed over the time of infection al-
though slightly elevated expression levels were also found 
in 24 h noninfected cells. Signifi cant differences were cal-
culated for expression levels in 24 h infected samples ver-
sus the respective negative control (p < 0.05). MiR-155-3p 
was signifi cantly upregulated in infected macrophages 5 h 
postinfection (p < 0.05). Twenty-four hours after infection, 
the expression level was similar to those of noninfected 
cells, whereas for miR-155-5p, expression level at 24 h re-
mained signifi cantly elevated (p < 0.05). The expression 
level of neither miR-155-3p nor 5p was affected 1 h af-
ter infection. Overall, miR-155-5p was accumulated to a 
higher degree compared to miR-155-3p. MiR-212-3p was 
increased 24 h postinfection compared to the noninfected 
control as well as compared to the other time points of 
infection (p < 0.05). Similar to miR-212-3p, miR-181c-5p 
as well as miR-21-3p was found to be upregulated 24 h 
after A. butzleri infection compared to other time points 
of infection. MiR-27a-5p showed an increased expression 
1 h after infection compared to the noninfected control 
(p < 0.05). MiRNA let-7a-3p (p < 0.05) and miR-26b-5p 
decreased over the time of infection (p < 0.05) whereas 
miR-148b-3p exhibited reduced expression levels 24 h 
 after infection (p < 0.05), and 1 h and 5 h after infection, 
expression was not affected. Highest miRNA copy num-
bers were found for miR-155-5p.
MiRNAs not yet associated with bacterial infections
MiR-3613, miR-2116, miR-671, miR-30d, and miR-629 
exhibited signifi cant differences in expression levels in in-
Fig. 1. (cont’d)
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fected macrophages. So far, none of these miRNAs have 
been described being commonly expressed in response to 
bacterial infection in human host cells.
As indicated in Fig. 2, miR-3613-5p exhibited elevated 
expression levels 5 h and 24 h postinfection compared to 
respective controls (p < 0.05). Expression remained unaf-
fected 1 h after infection. MiR-2116-3p and miR-671-3p 
were downregulated during infection 5 h and 24 h com-
pared to respective controls (p < 0.05). Expression of 
miR-30d-3p decreased over the time of infection; 5 h after 
infection, expression was signifi cantly reduced compared 
to the noninfected control (p < 0.05). Expression of miR-
30d-5p exhibited a similar pattern as expression of miR-
30d-3p did. Nevertheless, miR-30d-5p was accumulated 
to a much higher degree compared to miR-30d-3p. Ex-
pression of miR-629-5p was reduced 5 h after infection 
compared to noninfected cells (p < 0.05).
To unravel the role of these miRNAs, in silico predic-
tion was used to identify mRNA targets and pathways in 
which they accumulate. Beneath metabolic pathways, tar-
get accumulation was found for apoptosis/p53 signaling 
(targets of miR-3613 and miR-2116), MAPK signaling 
(targets of miR-671 and miR-30d-5p), endocytosis (tar-
gets of miR-30d-3p and 30d-5p), regulation of actin cy-
toskeleton (targets of miR-30d-3p), and formation of the 
immunoproteasome (targets of miR-629). The results are 
summarized in Table 3. Full data of the pathway analysis 
is attached in the supplementary data.
Fig. 2. MiRNAs not yet associated with bacterial diseases, expressed in primary human macrophages as a response to A. butzleri 
infection. Cells were infected at a MOI of 100. Samples were taken 1 h, 5 h, and 24 h after infection. Asterisks in figures summarize 
p values (*p < 0.05; **p < 0.01)
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Potential novel human miRNAs
Raw data analysis indicated potential novel miRNAs, 
which have not yet been described. To follow up the ex-
pression of respective transcripts, primers were designed 
and expression in the same macrophage samples used 
for RNAseq was investigated by means of miRNA spe-
cifi c RT-qPCR (miR-Q). Fold induction of potential novel-
miR-55 compared to the negative control increased over 
the time of infection; this was the case for both sequenc-
ing data (Fig. 3) and RT-qPCR analysis (Fig. 4). However, 
sequencing data indicated a downregulation of novel-
miR-55 in infected cells compared to respective negative 
controls, whereas in RT-qPCR data, novel-miR-55 was 
upregulated in infected cells. Transcript counts of poten-
tial novel-miRNAs in the analyzed samples are listed in 
Table 4. Potential novel-miR-134 was slightly upregulated 
5 h and 24 h in RNAseq data (Fig. 3). RT-qPCR indicated 
an upregulation in 24 h infected samples (Fig. 4). Expres-
sion dynamics of potential novel-miR-259 correlated in 
comparing RNAseq and RT-qPCR analysis. Again, as de-
scribed for novel-miR-55, RNAseq revealed a downregu-
Table 3. Pathways with enriched mRNA targets potentially infl uenced by A. butzleri-induced miRNAs
Pathway miRNAs mRNA targets p value
Endocytosis miR-30d-3p SH3GL3, DNM3, FLT1, ERBB4, STAM2, VTA1, 
PRKCI, ARF6, HLA-B, KIT, ZFYVE20, RAB31, 
AP2B1, RAB11FIP2, CHMP1B, RAB22A, RAB11B, 
VPS36, RNF41
0.063





miR-3613 CDK6, RRM2B, ATR, SESN3 0.037
miR-2116 IRAK2, IRAK1, IRAK3, PRKAR2A, DFFA, 
PIK3CB, CASP8, CHP2, EXOG, PPP3R2, PIK3R1
0.076
EI24, CD82, RRM2, SERPINE1, CASP8, RCHY1, 
RRM2B, MDM4, PERP, CDK2, SESN3
0.017
Regulation of actin 
cytoskeleton
miR-30d-3p GNA13, FGF7, PIK3CB, ROCK2, DIAPH2, SSH2, 
GNA12, ITGA1, ACTN2, PPP1CB, NCKAP1, 
DOCK1, CHRM2, TIAM1, SOS1, SOS2, WASL, 




miR-671 RASGRF1, FGF11, CACNB3, FGF1, CRK 0.063
miR-30d-5p MAP3K7, CASP3, MAP3K5, TAOK1, MAP3K2, 




miR-629 PSMA2, PSMB10, PSMD13, PSMB2, PSME4 0.023
Table 4. Mean counts of potential novel-miRNA transcripts in infected cells (A.b.) and controls (n.c.) 
determined by RNAseq
miRNA A.b. 1 h n.c. 1 h A.b. 5 h n.c. 5 h A.b. 24 h n.c. 24 h
Novel-miR-55  1.3  3.7  1.7  2.7  0.7  1.3
Novel-miR-134  2  1.3  3.7  1.3  4  1.7
Novel-miR-259 43.3 58 27 56 23 37
Fig. 3. RNA sequences were analyzed for potential novel miRNA sequences using mirDeep2 algorithms [13]
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lation in infected cells (Fig. 3), whereas RT-qPCR indi-
cated an upregulation (Fig. 4).
Discussion
Several studies have shown that miRNAs are key regula-
tors of innate immunity [19–21] and play a prominent role 
in the specifi c host response towards bacterial pathogens 
[22, 23]. We have previously demonstrated that A. butzleri 
induce a pro-infl ammatory response in human macro-
phages and have limited ability for intracellular survival 
[10]. Since nothing is yet known about underlying regula-
tory mechanisms such as miRNA expression in response 
to infection, we challenged primary human macrophages 
with A. butzleri and analyzed miRNA expression by means 
of RNAseq.
Bioinformatic investigation of generated sequencing 
data revealed several miRNAs, which were differentially 
expressed in infected cells compared to the noninfected 
control. Some of these miRNAs have not yet been reported 
to play a role in the host response towards bacterial infec-
tion. However, most of the identifi ed miRNAs belonged to 
a set of candidates, which were also expressed in immune 
cells in response to bacterial infection or LPS stimulus in 
previous studies (miR-155, miR-21, miR-125, miR-212, 
let-7a, miR-181c, miR-26b, miR-148a, and miR-27a) 
[24–28].
Among these, miR-155, miR-21, miR-125, and let-7a 
play a central role in the immune response towards bac-
terial pathogens [3, 25]. They are mainly regulated in a 
Toll-like receptor dependent manner and, in turn, target 
different components of the TLR signaling cascade in-
cluding TLRs themselves as well as downstream signal-
ing proteins such as MyD88 and transcription factors 
such as NFκB as well as cytokines. MiRNAs can thereby 
control strength, location, and timing of TLR response 
[19], which makes them crucial for a balanced immune 
homeostasis and protects the host from uncontrolled in-
fl ammatory conditions. Notably, expression of miR-146 
did not display signifi cant differences in A. butzleri-in-
fected cells compared to the noninfected control, even 
though it is reported to act as a key regulator of TLR 
signaling in immune cells in response to various bacte-
rial pathogens such as Campylobacter concisus, Helico-
bacter pylori, or Salmonella enterica [4, 29]. This might 
be due to expression dynamics in the course of infection. 
Nevertheless, in THP-1-derived macrophages infected 
with C. concisus (another member of the family of Cam-
pylobacteraceae), miR-146a was upregulated 6 h after 
infection [29].
Interestingly, some differentially expressed miRNAs 
identifi ed in macrophages in response to A. butzleri have 
not been reported yet as regulators of host response to 
infection (miR-3613, miR-2116, miR-671, miR-30d-3p, 
miR-30d-5p, and miR-629-5p). In silico analysis employ-
ing miRmap software and DAVID functional annotation 
tool revealed that potential targets of these miRNAs (be-
sides putative targets in metabolism and cancer) were 
enriched in pathways such as apoptosis/DNA damage, 
MAPK signaling, endocytosis, regulation of actin cyto-
skeleton, and formation of the immunoproteasome. Except 
for miR-3613, all miRNAs that were not yet associated 
with bacterial infections were downregulated during Arco-
bacter challenge.
In case of apoptosis, possibly involved miR-2116 was 
downregulated 24 h after infection. MiRmap revealed 
the initiator caspase 8 as a potential target. Therefore, 
an increased caspase activity due to the loss of miRNA-
inhibition leading to onset of apoptosis in the course of 
infection could be hypothesized. The induction of apopto-
sis in macrophages to enhance virulence has been shown 
for several bacterial pathogens such as Salmonella spp. or 
Shigella fl exneri [30] and could favor the establishment of 
A. butzleri infection by impairing phagocytosis and eradi-
cation by immune cells. The regulatory role of miRNAs in 
apoptosis is well known [31], and the modulation of host 
miRNA expression to attenuate macrophage function has 
been demonstrated for pathogens such as Mycobacterium 
avium [4, 23]. Although we were able to demonstrate the 
initial activation of initiator as well as effector caspases 
in THP-1-derived macrophages in response to A. butzleri 
infection in a previous study [10], DNA damage and end-
point apoptosis could not be detected. However, this could 
be different in primary human macrophages and needs to 
be the matter of deeper investigations. In case of endocy-
tosis, possibly involved miR-30d-3p and miR-30d-5p were 
downregulated in A. butzleri-challenged cells, suggesting 
Fig. 4. Expression of respective novel sequences in macrophage samples were followed up by means of RT-qPCR (miR-Q)
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a miRNA-mediated boost of endocytosis in response to 
Arcobacter infection.
In addition, three potential novel miRNAs (novel-
miR-55, novel-miR-134, and novel-miR-259) were iden-
tifi ed in A. butzleri-infected macrophages and expression 
was followed up by RT-qPCR. Nevertheless, further ex-
periments are necessary to validate the expression of the 
novel miRNAs and their functional role.
Overall, the miRNA response of macrophages towards 
A. butzleri infection differed from recent fi ndings regard-
ing infection of THP-1 cells with C. concisus [29]. There 
were no overlaps in miRNA expression in both studies 
underlining the observation that differences in expres-
sion levels and profi les depend on the stimulus and cell 
type [19]. This study suggests that macrophage function 
is controlled by a specifi c set of miRNAs during A. butz-
leri infection. These miRNAs may not only constitute a 
potential therapeutic target but also function as promising 
diagnostic marker for the infection.
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